A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2

ABSTRACT: A Study of XMT-2056 in advanced/recurrent solid tumors that express HER2.

DISEASE(S): Her2-positive Tumors,Her2-positive Non-small Cell Lung Cancer,Her2-positive Colorectal Cancer,Her2-positive Gastric Cancer,Her2 Low Breast Cancer,Her2-positive Breast Cancer,Breast Neoplasms

PROVIDER: 2746280 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR